Gen-t is a genomics platform for R&D
gen-t has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
gen-t's investors include Roivant Sciences, Eduardo Mufarej, Eurofarma Ventures, Armínio Fraga, Daniel Gold.
gen-t is headquartered in São Paulo, Brazil.
Gen-t is a genomics platform for R&D
gen-t is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"gen-t — Funding & Investors." VCBacked, October 9, 2023, https://www.vcbacked.co/company/gen-t. Accessed August 15, 2026.
VCBacked. (2023). gen-t — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/gen-t
{{cite web |title=gen-t — Funding & Investors |url=https://www.vcbacked.co/company/gen-t |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated